NCT00687284已完成不适用
Observational Study on Evaluation of Glycaemic Control in Patients Using Levemir® (Insulin Detemir) as Initiation Insulin Therapy by Levemir® (Insulin Detemir) Administered Once Daily as the Treatment for Type 2 Diabetes Mellitus.
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,188
- 试验地点
- 1
- 主要终点
- Change in glycaemic control as measured by HbA1c.
研究概览
简要总结
This study is conducted in Europe. An observational study evaluating glycaemic control in patients using Levemir® as initiation insulin therapy as the treatment of type 2 diabetes in Slovakia.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with type 2 diabetes
- •Patients inadequately controlled by OAD
- •Patients willing to sign informed consent
- •Selection of study participants at the discretion of the physician
- •Particular attention should be paid to the drug interactions that are listed within the product label
排除标准
- •Subjects who are unlikely to comply with protocol, e.g., uncooperative attitude, inability to return for the final visit;
- •Subjects who were previously enrolled in this study
- •Subjects with a hypersensitivity to insulin detemir or to any of the excipients.
- •Women who are pregnant, breastfeeding or have the intention of becoming pregnant within next 6 months
研究组 & 干预措施
A
干预措施: insulin detemir (Drug)
结局指标
主要结局
Change in glycaemic control as measured by HbA1c.
时间窗: For the duration of the study
次要结局
- The effect on glycaemic control as measured by FPG(After 12 weeks and 24 weeks)
- Change in body weight(After 12 weeks and 24 weeks)
- Change in waist and hip perimeter(After 12 weeks and 24 weeks)
- Percentage of subjects to reach HbA1c below 7.0% and below or equal 6.5%(After 12 weeks and 24 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinDiabetesDiabetes Mellitus, Type 2NCT00670722Novo Nordisk A/S6,500
已完成
不适用
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinDiabetesDiabetes Mellitus, Type 2NCT00676741Novo Nordisk A/S3,809
已完成
不适用
Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin TreatmentDiabetesDiabetes Mellitus, Type 2NCT00865397Novo Nordisk A/S1,032
已完成
不适用
Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose ControlDiabetesDiabetes Mellitus, Type 2NCT00700960Novo Nordisk A/S2,745
已完成
不适用
Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT01288326Novo Nordisk A/S254